Lucid Announces Q2 Production & Deliveries, Sets Date for Second Quarter 2025 Results

Lucid Group, Inc. (NASDAQ: LCID), maker of the world's most advanced electric vehicles, today announced production and delivery totals for the quarter ended June 30, 2025. During this period, Lucid produced 3,863 vehicles and delivered 3,309 vehicles. During the six months ended June 30, 2025, Lucid produced 6,075 vehicles and delivered 6,418 vehicles.1 https://mma.prnewswire.com/media/1080273/LucidMotors_Logo.jpg Lucid […]

Emergent BioSolutions Expands NARCANDirect(R) to Offer KLOXXADO(R) (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate

Emergent BioSolutions Expands NARCANDirect(R) to Offer KLOXXADO(R) (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate Starting July 1, 2025, additional opioid overdose response tools will be available to continue addressing evolving patient and customer needs to combat public health crisis GlobeNewswire July 02, 2025 GAITHERSBURG, Md., July 02,

PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share

PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share GlobeNewswire July 02, 2025 MIAMI, July 02, 2025 (GLOBE NEWSWIRE) — PennantPark Investment Corporation (the “Company”) (NYSE: PNNT) declares its monthly distribution for July 2025 of $0.08 per share, payable on August 1, 2025 to stockholders of record as of July 15, 2025. The distribution

Julong Holding Limited Announces Full Exercise of Over-Allotment Option

Julong Holding Limited Announces Full Exercise of Over-Allotment Option GlobeNewswire July 02, 2025 BEIJING, July 02, 2025 (GLOBE NEWSWIRE) — Julong Holding Limited (“Julong” or the “Company”) (Nasdaq: JLHL), a growth-oriented provider of intelligent integrated solutions, today announced that, in connection with its previously completed initial public offering (the “Offering”) of its Class A ordinary

Lixte Biotechnology Holdings, Inc. Announces the Closing of $5.0 Million Private Placement Priced at the Market

(NASDAQ:LIXT),(NASDAQ:LIXTW), PASADENA, CALIF, July 02, 2025 (GLOBE NEWSWIRE) — Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a clinical stage pharmaceutical company, today announced the closing of a private placement with accredited investors for the purchase and sale of approximately $5.0 million of shares of Common Stock (or Pre-Funded Warrants), Series B Convertible Preferred Stock

EuroDry Ltd. Announces Annual Meeting of Shareholders

(NASDAQ:EDRY), ATHENS, Greece, July 02, 2025 (GLOBE NEWSWIRE) — EuroDry Ltd. (NASDAQ: EDRY, the “Company” or “EuroDry”), an owner and operator of drybulk vessels and provider of seaborne transportation for drybulk cargoes, announced today that its Board of Directors has called an annual meeting of the shareholders to be held on July 23, 2025, at

4DMT Announces Accelerated 4D-150 Phase 3 Development in Wet AMD and Streamlined Organization to Drive Late-Stage Execution

(NASDAQ:FDMT), 4FRONT-1 Phase 3 expected data readout accelerated from H2 2027 to H1 2027 4FRONT-2 Phase 3 trial initiated ahead of schedule Streamlined late-stage clinical and pre-commercial organization aligns with focused pipeline shift, as announced in January 2025 EMERYVILLE, Calif., July 02, 2025 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company),

QCR Holdings, Inc. to Report Second Quarter 2025 Financial Results

(NasdaqGM:QCRH), MOLINE, Ill., July 02, 2025 (GLOBE NEWSWIRE) — QCR Holdings, Inc. (NASDAQ: QCRH) (“QCRH” or the “Company”) announced today that its second quarter ended June 30, 2025, financial results will be released after the market closes on Wednesday, July 23, 2025. The Company will host a conference call and webcast the next day, Thursday,

Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028

(NYSE:ITGR), PLANO, Texas, July 02, 2025 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading medical device contract development and manufacturing organization, today notified holders of its 2.125% Convertible Senior Notes due 2028 (the “Notes”) that the Notes are convertible, at the option of the holders (the “Conversion Option”) beginning

Safe Bulkers, Inc. Declares Quarterly Dividend on its 8.00% Series C Cumulative Redeemable Perpetual Preferred Shares; 8.00% Series D Cumulative Redeemable Perpetual Preferred Shares

(NYSE:SB),(NYSE:SB-PC),(NYSE:SB-PD), MONACO, July 02, 2025 (GLOBE NEWSWIRE) — Safe Bulkers, Inc. (the “Company”) (NYSE: SB), an international provider of marine drybulk transportation services, announced today that the Company's Board of Directors has declared: a cash dividend of $0.50 per share on its 8.00% Series C Cumulative Redeemable Perpetual Preferred Shares (the “Series C Preferred Shares”)

Scroll to Top